HER2-positive Colorectal Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB18230XMT-20561Suspended1
DB01101Capecitabine1 / 2Terminated1
DB09035Nivolumab1 / 2Recruiting1
DB00072Trastuzumab1 / 2Terminated1
DB14962Trastuzumab deruxtecan1 / 2Terminated1
DB11652Tucatinib1 / 2Terminated1
DB18411Anbenitamab2Not Yet Recruiting1
DB17446Erfonrilimab2Not Yet Recruiting1